Business Description
Xiangyu Medical Co Ltd
ISIN : CNE100005394
Share Class Description:
SHSE:688626: Class ACompare
Compare
Traded in other countries / regions
688626.China IPO Date
2021-03-31Description
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.18 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 2.38 | |||||
| Interest Coverage | 31.44 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.06 | |||||
| Beneish M-Score | -2.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5 | |||||
| 3-Year EBITDA Growth Rate | -4.5 | |||||
| 3-Year EPS without NRI Growth Rate | 0.3 | |||||
| 3-Year Book Growth Rate | 28.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 21.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.64 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.47 | |||||
| 9-Day RSI | 45.19 | |||||
| 14-Day RSI | 48.57 | |||||
| 6-1 Month Momentum % | -16.57 | |||||
| 12-1 Month Momentum % | -43.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.81 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 1.17 | |||||
| Days Inventory | 381.39 | |||||
| Days Sales Outstanding | 27.11 | |||||
| Days Payable | 142.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.67 | |||||
| Dividend Payout Ratio | 0.63 | |||||
| Forward Dividend Yield % | 1.67 | |||||
| 5-Year Yield-on-Cost % | 1.68 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -0.3 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.39 | |||||
| Operating Margin % | 17.17 | |||||
| Net Margin % | 17.11 | |||||
| FCF Margin % | -41.54 | |||||
| ROE % | 5.92 | |||||
| ROA % | 4.5 | |||||
| ROIC % | 5.97 | |||||
| ROC (Joel Greenblatt) % | 14.54 | |||||
| ROCE % | 6.46 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 40.92 | |||||
| Forward PE Ratio | 16.41 | |||||
| PE Ratio without NRI | 37.33 | |||||
| PEG Ratio | 5.57 | |||||
| PS Ratio | 6.91 | |||||
| PB Ratio | 2.49 | |||||
| Price-to-Tangible-Book | 2.79 | |||||
| Price-to-Operating-Cash-Flow | 32.44 | |||||
| EV-to-EBIT | 33.23 | |||||
| EV-to-EBITDA | 33.23 | |||||
| EV-to-Revenue | 6.61 | |||||
| EV-to-FCF | -16.3 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.57 | |||||
| Price-to-Graham-Number | 2.15 | |||||
| Price-to-Net-Current-Asset-Value | 14.19 | |||||
| Earnings Yield (Greenblatt) % | 3.01 | |||||
| FCF Yield % | -5.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xiangyu Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 709.565 | ||
| EPS (TTM) (Â¥) | 0.77 | ||
| Beta | 1.37 | ||
| Volatility % | 46.2 | ||
| 14-Day RSI | 48.57 | ||
| 14-Day ATR (Â¥) | 2.072194 | ||
| 20-Day SMA (Â¥) | 32.544 | ||
| 12-1 Month Momentum % | -43.75 | ||
| 52-Week Range (Â¥) | 21.58 - 54 | ||
| Shares Outstanding (Mil) | 160 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xiangyu Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xiangyu Medical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xiangyu Medical Co Ltd Frequently Asked Questions
What is Xiangyu Medical Co Ltd(SHSE:688626)'s stock price today?
The current price of SHSE:688626 is ¥31.51. The 52 week high of SHSE:688626 is ¥54.00 and 52 week low is ¥21.58.
When is next earnings date of Xiangyu Medical Co Ltd(SHSE:688626)?
The next earnings date of Xiangyu Medical Co Ltd(SHSE:688626) is .
Does Xiangyu Medical Co Ltd(SHSE:688626) pay dividends? If so, how much?
The Dividend Yield %  of Xiangyu Medical Co Ltd(SHSE:688626) is 1.67% (As of Today), Highest Dividend Payout Ratio of Xiangyu Medical Co Ltd(SHSE:688626) was 0.78. The lowest was 0.18. And the median was 0.37. The  Forward Dividend Yield % of Xiangyu Medical Co Ltd(SHSE:688626) is 1.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers